Stock SEER SEER, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Seer, Inc.

Equities

SEER

US81578P1066

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-07-08 pm EDT 		5-day change 1st Jan Change
1.6 USD -1.23% Intraday chart for Seer, Inc. -5.33% -17.53%
Jul. 01 Seer, Inc.(NasdaqGS:SEER) dropped from Russell Small Cap Comp Value Index CI
Jul. 01 Seer, Inc.(NasdaqGS:SEER) dropped from Russell Small Cap Completeness Index CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Seer Proteograph™ Provides Differentiated Insights into Spaceflight Proteomic Alterations for Precision Medicine and Biomarker Discovery
GL
Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Early Cancer Detection Study
AQ
Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Early Cancer Detection Study
GL
Seer Reports First Quarter 2024 Financial Results
GL
Seer Launches New Technology Access Center in Europe to Expand Accessibility to Unbiased Proteomic Solutions
GL
Seer to Report First Quarter 2024 Financial Results on May 8, 2024
GL
Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook
GL
Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook
AQ
Seer to Participate in the TD Cowen 44th Annual Health Care Conference
GL
Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery
GL
Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery
AQ
Seer to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024
GL
Seer to Present at the J.P. Morgan 42nd Annual Health Care Conference
GL
Seer : Investor Presentation
PU
Seer to Present at the Canaccord MedTech, Diagnostics and Digital Health & Services Forum
GL
Seer Wins Proteomics Solution of the Year by BioTech Breakthrough and Named #5 on Deloitte Technology Fast 500
GL
Seer Wins Proteomics Solution of the Year by BioTech Breakthrough and Named #5 on Deloitte Technology Fast 500
AQ
Seer Reports Third Quarter 2023 Financial Results
GL
Seer Reports Third Quarter 2023 Financial Results
AQ
Seer Announces Addition of Panome Bio to Centers of Excellence (COE) Program
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SEER Stock
  4. News Seer, Inc.
  5. Press Releases